MLAB peer analysis
Mesa Laboratories (MLAB) against its competitors: price, today's move, 1-year return and market value side by side.
MLAB and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| A Agilent | $171.99 | -1.65% | 17.51% | – |
| BIO Bio-Rad | $366.16 | -1.62% | 14.59% | $9.95B |
| LAB Standard BioTools | $0.61 | -0.02% | -49.18% | – |
| MRVI Maravai LifeSciences | $7.19 | -7.94% | 128.98% | – |
| PACB Pacific Biosciences | $2.37 | 1.07% | 1.28% | $809.71M |
| QGEN QIAGEN | $50.34 | -0.01% | 7.46% | $10.37B |
| RVTY Revvity | $160.26 | 5.71% | 71.24% | – |
| TECH Bio-Techne | $72.67 | 0.01% | 16.14% | $11.41B |
| TMO Thermo Fisher | $683.01 | 0.05% | 20.38% | $257.71B |
| TXG 10x Genomics | $62.00 | 0.60% | 354.55% | $9.13B |
| MLAB Mesa Laboratories | $121.97 | -4.57% | 69.66% | $715.21M |
- MLAB's peers: A (Agilent), BIO (Bio-Rad), LAB (Standard BioTools), MRVI (Maravai LifeSciences), PACB (Pacific Biosciences), QGEN (QIAGEN), RVTY (Revvity), TECH (Bio-Techne).
Updated 2026-11-03 13:28 UTC